Brind.
  1. Amgen is involved in a settlement with INPRS over drug safety claims, while also acquiring ChemoCentryx Inc. amid FDA scrutiny.

Amgen acquired ChemoCentryx, a company employing Huibin Yue and Pirow Bekker. Amgen is now submitting data to counter claims made by the FDA.

1 report, 1 independent Updated Jul 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Amgen acquired ChemoCentryx, a company employing Huibin Yue and Pirow Bekker. Amgen is now submitting data to counter claims made by the FDA.

Who's involved

What this event is mainly about
AmgenFDA

Keep exploring

Part of

Amgen is involved in a settlement with INPRS over drug safety claims, while also acquiring ChemoCentryx Inc. amid FDA scrutiny. All 1 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped